Introduction
As the prevalence of coronary atherosclerosis has generally been demonstrated to be low, the determinants and clinical association of coronary artery disease (CAD) are not well characterized for young patients. 1 -3 Importantly, prior studies that have investigated the prevalence of coronary atherosclerosis in the young have been limited to small populations, 4 -11 and the association between CHD and risk factors (RFs) has been inadequately examined.
. and/or coronary revascularization) and 173 patients with coronary anomaly. Among 1635 remaining patients-defined as 45 years of age or younger-met inclusion criteria for the current study. The age threshold for inclusion in the study criteria was chosen in accordance with prior investigations of young patients, as well as from empirical evidence by CCTA of an exceedingly low prevalence of CAD in this population. Before the scan, physicians or dedicated nurse professionals prospectively collected information on the presence of categorical CAD RFs in each individual. Systemic arterial hypertension was defined as a documented history of high blood pressure or treatment with antihypertensive medications. Diabetes mellitus was defined by diagnosis of diabetes made previously by a physician and/or use of insulin or oral hypoglycaemic agents. Dyslipidaemia was defined as known but untreated dyslipidaemia or current treatment with lipid-lowering medications.
A positive smoking history was defined as current smoking or cessation of smoking within 3 months of testing. Positive family history (FH) of CAD was determined by patient query and was defined as a MI, sudden cardiac death, or need for coronary revascularization in a first-degree relative. Body mass index (BMI) was calculated according to the formula: weight/height in kg/m 2 . Chest pain symptom was defined as non-cardiac, atypical, or typical angina.
Coronary CTA acquisition
CCTAs were performed on a single-source, 64-slice scanner (Lightspeed VCT, GE Healthcare, Milwaukee, WI, USA; SOMATOM Sensation 64, Siemens Medical Systems, Erlangen, Germany) or dual-source scanner (Definition or Flash, Siemens Medical Systems). Before imaging, in patients without contraindications, oral and/or intravenous metoprolol was administered in an attempt to achieve a target heart rate ≤65 bpm for single-source scanners or ≤75 bpm for dual-source scanners. Whenever possible, 0.4 mg sublingual nitroglycerin was administered 3 -5 min before image acquisition. Timing bolus or automated bolus tracking at the proximal ascending aorta was used to determine the time from contrast injection to optimal coronary artery enhancement. Contrast (80-140 mL, depending on site) was injected at 5-6 mL/s (rates .6 mL/s were reserved for very obese patients or patients with very thick chests), and whole-volume image acquisition was completed in a single breath-hold. Acquired image data were initially reconstructed in mid diastole (always) and end systole (when available). When image quality was suboptimal on initial reconstruction, multisector reconstruction algorithm with or without manual electrocardiogram (ECG) editing was used to improve image quality. Reconstructed data were then sent to a workstation, where a minimum of 1 level III equivalent and/or board-certified reader in cardiovascular computed tomography employed all necessary postprocessing techniques to determine the presence of CAD in any visible segment ≥2 mm in diameter, with obstructive CAD defined as a luminal diameter stenosis .50%. Any CAD was defined as the presence of any plaque regardless of luminal diameter stenosis.
CCTA interpretation
CCTA interpretation was performed in an intent-to-diagnose fashion for all CCTAs, in accordance with prior reported investigations. All uninterpretable segments were scored with the same stenosis severity as the most adjacent proximal evaluable segment, in accordance with standard protocols from prior multicentre studies. 13, 14 A 16-segment AHA coronary artery tree model was used. 15 Coronary atherosclerotic lesions were quantified for lumen diameter stenosis by visual estimation and graded as none (0% luminal stenosis), mild (1 -49%), moderate (50 -69%), or severe (≥70%). Plaque composition in each coronary segment was classified as calcified, non-calcified, or partially calcified as we have previously described, 16 and the presence of any plaque, calcified, non-calcified, and partially calcified plaque was also evaluated. Plaque severity was scored on a per-patient, per-vessel, and persegment level. Per-patient maximal plaque severity was defined by maximal intraluminal stenosis in any of the coronary segments at the 50% stenosis threshold. Any CAD was defined as patients who had any plaque, irrespective of grade of stenosis.
Statistical analysis
All statistical calculations were performed using STATA (Version 11, StataCorp LP, College Station, TX, USA) and SAS version 9. 
Results
Clinical characteristics of the study cohort
Characteristics of study population are detailed in Table 1 . Among 1635 subjects, 70% was men, 6% had diabetes, 37% had dyslipidaemia, 31% had hypertension, 21% had current smoking, and 33% had FH of CAD. 
CCTA findings associated with gender and CAD risk
Among all study subjects, any CAD, obstructive CAD, CP, and NCP were observed in 19, 4, 5, and 8%, respectively. Compared with women, men demonstrated higher rates of any CAD (21 vs. 12%, P , 0.001), NCP (9 vs. 5%, P ¼ 0.008), and CP (6 vs. 3%, P ¼ 0.01), although no difference was observed for rates of obstructive CAD (5 vs. 4%, P ¼ 0.46). Any CAD, obstructive CAD, and NCP were significantly higher for individuals with diabetes, current smoking, dyslipidaemia, FH of CAD or hypertension; only diabetes and dyslipidaemia were significantly associated with CP ( Table 2 ).
Impact of gender or CAD risk factors on coronary atherosclerosis
In multivariable logistic regression analyses considering age and CAD risk factors, male gender was the strongest predictor for any CAD (OR ¼ Table 3 ).
Impact of number of CAD RFs on coronary atherosclerosis
Increasing CAD RFs was associated with greater prevalence, extent, and severity of CAD, with individuals with 0, 1, 2, ≥3 RFs manifesting a dose -response increase in CP (P ¼ 0.008, for trend), NCP (P , 0.001, for trend), any CAD (P , 0.001, for trend), and obstructive CAD (P , 0.001, for trend). For male subjects, increasing number of RFs was also associated with a greater frequency of CP (P ¼ 0.045, for trend), NCP (P , 0.001, for trend), any plaque (P , 0.001, for trend), and obstructive CAD (P , 0.001, for trend). However, for female Figure 1 Association between coronary atherosclerosis and number of cardiovascular RFs for (A) the entire study cohort, (B) for male subjects, and (C) for female subjects. CAD, coronary artery disease; obst CAD, obstructive coronary artery disease, pre CP, presence of calcified plaque; pre NCP, presence of non-calcified plaque.
Coronary risk factors and atherosclerosis in young adults subjects, increasing number of RFs was not significantly associated with CP (P ¼ 0.085, for trend), while that was significantly correlated with NCP (P ¼ 0.001, for trend), any CAD (P ¼ 0.014, for trend), and obstructive CAD (P , 0.001, for trend) ( Figure 1) . When classified by symptom state, asymptomatic patients with increasing numbers of RFs possessed increased CP, NCP, any CAD, and obstructive CAD, a finding that was evident more for males than for females (Figure 2 ). For symptomatic patients, these trends were observed for NCP, any CAD, and obstructive CAD but not CP (Figure 3) . These relationships were similar for men and women.
Discussion
In this prospective, multicentre international study of young patients ,45 years of age, we examined prevalence and severity of CAD and their association to gender and CAD RFs. Further, we examined the relationship of demographic and CAD RFs to coronary plaque composition in a fashion that has not been previously studied. We identified a common occurrence of CAD by CCTA in young individuals, with approximately one in five individuals exhibiting any CAD. Further, despite their young age, there existed a 1 in 20 prevalence of obstructive CAD in these individuals referred for clinically indicated CCTA. These prevalences were disproportionate when comparing gender and CAD RFs, with increasing rates of any obstructive CAD in male individuals compared with their female counterpart, as well as for individuals with increasing numbers of traditional RFs. These observational findings indicate an early pathogenesis of manifest atherosclerosis that may help inform future interventions aimed at halting progression of the insidious CAD process. Prior autopsy-based studies investigating young soldiers who died from non-cardiac causes have demonstrated that coronary atherosclerosis begins early in life. These pathologic studies reported a frequency of coronary atherosclerosis to be 77.3% among Korean war-era soldiers, 5, 6, 11 while Vietnam war soldiers exhibited identifiable coronary atherosclerosis in only 45%, with more severe coronary atherosclerosis observed in 5%. 9 Subsequent autopsy studies reported that the incidence of coronary stenosis increases with age in studies with subjects ranging from 21 to 39 or 30 to 34 years, 4, 7 and a higher atherosclerosis presence in men than in women. 8 More contemporary analyses employing intravascular ultrasound (IVUS) on 262 donor heart of a mean age of 33.4 + 13.2 years within 1 month of cardiac transplantation observed a prevalence of coronary atherosclerosis that varied from 17% in donor hearts from individuals ,20 years of age to 85% in donor hearts from individuals ≥50 years of age.
10 Figure 2 Association between coronary atherosclerosis and number of cardiovascular RFs among asymptomatic patients according to (A) the entire study cohort, (B) for male subjects, and (C) for female subjects.
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The explanation of the variability of CAD prevalence in these studies is likely multi-fold in nature, but it may certainly be linked to different study subjects, different methods of CAD examination, dissimilar definitions of coronary atherosclerosis, and small study populations. Our present study findings directly extend these prior studies by prospective evaluation of a significantly larger population that is international in scope, employing a more systematic and comprehensive evaluation of coronary atherosclerosis by a non-invasive method with high diagnostic performance. Importantly, among the study cohort, 70% were asymptomatic and suggest a hypothesis-generating notion that these findings may be similar in a population-based study. The results of this present study should be viewed with caution. Given the lack of prognostic data associated with the study, no concrete conclusion can be drawn regarding the need or timing of early treatment in young patients for reduction of future adverse cardiovascular events. Future larger studies evaluating the prognostic utility of any CAD, CP, and NCP will be needed to address this question.
Previous epidemiologic studies have demonstrated a significant association between subclinical coronary atherosclerosis and RFs even in children, adolescents, and young adults. 4, 8, 17, 18 Given its magnitude, the current study was able to further expand these prior findings by assessing the relationship of sex and CAD risk factors to the prevalence and severity of coronary atherosclerosis. In this regard, we identified male gender as the strongest predictor of any coronary atherosclerosis, as well as for the presence of both CP and NCP in young patients. We were able not only to identify which demographic and CAD RFs are associated with higher CAD prevalence, but also the degree to which these factors predict CAD presence, severity, and plaque composition. One prior prospective cohort deserved to be mentioned, having analysed 14 786 middle-aged (age: 25 -64 years) men and women in Finland, and investigators found that relative difference in CHD risk between sexes was largest among 25 -49 year old, 19 a finding that is in direct accordance with the present study. 2 These observations may be explained, in part, by several studies that have demonstrated a cardioprotective effect of oestrogen through glucose metabolism and haemostatic system; 20, 21 although an array of other factors deserve equal consideration. Interestingly, in this Finnish study, differences in RFs were more favourable in women, but sex differences in RF levels diminished with increasing age. 19 These findings suggest a cumulative differential progression of atherosclerosis due to higher rates of RFs and longer exposure in men than in women. In the present study, FH of CAD was the strongest predictor for obstructive CAD. This result is concordant with the prior studies that have shown an association between coronary atherosclerosis and FH of CAD in young patient, 22, 23 and the quantification of the direct association of this factor is likely Figure 3 Association between coronary atherosclerosis and number of cardiovascular RFs among symptomatic patients according to (A) the entire study cohort, (B) for male subjects, and (C) for female subjects. CAD, coronary artery disease; obst CAD, obstructive coronary artery disease; pre CP, presence of calcified plaque; pre NCP, presence of non-calcified plaque.
explained by both genetic and environmental factors. 24 Future studies will be invaluable to further assess this novel observation. Finally, we have also determined that increasing prevalence of CAD RFs were significantly associated with the presence of CP, NCP, any CAD, and obstructive CAD. These results may suggest that CAD treatment measures in young patients at the time of atherosclerosis identification may be salutary in nature, and future studies would be useful to evaluate the therapeutic benefit of treatment of early coronary atherosclerosis.
Study limitations
This study is not without limitations. First, our study findings were derived from a cohort of individuals who were referred for clinically indicated CCTA by their physician for suspected CAD, and thus, extrapolation of our study findings to population-based cohorts should be done with caution. Secondly, our study findings indicate the significant associations between the presence and extent of coronary atherosclerosis self-report which may be subject to ascertainment bias; however, this method is that which is commonly applied in clinical practice, and thus, the results of our multinational study may be considered widely generalizable. Third, given the current limited spatial and temporal resolution of CCTA, it remains possible that CAD was underestimated compared with IVUS or autopsy studies. Fourth, the radiation dose conferred by CCTA is non-negligible, and care must be taken to minimize exposure in this young population, given the hypothetical risk of future cancers. Fifth, current generation CCTA is dependent on single-energy image acquisition and calcium artefacts-including 'blooming' from partial volume artefacts are still known to occur. While the present manuscript employed standard definitions of CP that have been used consistently in prior investigations, the likelihood of small degrees of NCP obscured by CPs cannot be discounted. These findings could also be influenced by the 'real-world' design of the study which did not employ a dedicated core laboratory for image interpretation. Notably, all CCTA readers were Level III-equivalent physicians with extensive experience interpreting CCTAs. Further, the pharmacologic therapy of the study cohort was not known nor were changes in treatment after the CCTA. Future studies evaluating these findings as it relates to CAD progression and prognosis are necessary and are currently being pursued by our laboratory. Sixth, the cross-sectional nature of the current study limited the long-term assessment of the conventional RFs and how they might influence the risk of CAD progression over time. Forthcoming longitudinal studies utilizing timeupdated measures are needed to further our understanding of how the conventional RFs might impact the progression of CAD. Finally, the prognostic utility of the findings related to any CAD and the presence of CP or NCP was not examined in the present study. Larger observational cohort studies are needed to determine the ability of these CAD findings by CCTA to further risk stratify patients beyond traditional CAD risk factors.
Conclusion
Any CAD and obstructive CAD are present in 1 in 5 and 1 in 20 young individuals, respectively, with FH associated with the greatest risk of obstructive CAD.
